Hedley D W, Hallahan A R, Tripp E H
Ludwig Institute for Cancer Research, University of Sydney, NSW, Australia.
Br J Cancer. 1990 Jan;61(1):65-8. doi: 10.1038/bjc.1990.14.
Rice et al. (1986) have described a flow cytometric method where the non-fluorescent probe monochlorobimane (mBCl) forms a fluorescent adduct with cellular glutathione (GSH) under the action of glutathione-S-transferase. We show here that for EMT6 carcinosarcoma cells there is a close correlation between mean cell fluorescence, expressed as a ratio to that of fluorescence calibration beads, and biochemically determined GSH content over the range 0.2-2.0 fmol cell-1. Single cell suspensions from 14 human cancers were prepared by 23-gauge needle aspiration or mechanical disaggregation of surgical specimens, stained using mBCl and examined by flow cytometry. There was a wide range in individual cell fluorescence, which in contrast to EMT6 cells was not strongly correlated with Coulter volume. By comparing tumour cell fluorescence to that of calibration beads, and assuming that the relationship with GSH content for EMT6 holds for other cells, a mean GSH content of 0.95 fmol cell-1 was derived for nine carcinomas, and 0.21 fmol cell-1 for five non-Hodgkin's lymphomas. Although this semi-quantitation needs further validation, the method used here is rapid, gives an indication of heterogeneity of tumour cell GSH content, and can be applied to fine needle biopsy samples. It therefore shows promise as a means for studying prospectively the relationship of GSH content to clinical drug and radiation sensitivity, and for monitoring the effects of agents such as buthionine sulphoximine which are intended to improve treatment results through tumour cell GSH depletion.
赖斯等人(1986年)描述了一种流式细胞术方法,其中非荧光探针单氯双硫腙(mBCl)在谷胱甘肽-S-转移酶的作用下与细胞内谷胱甘肽(GSH)形成荧光加合物。我们在此表明,对于EMT6癌肉瘤细胞,以与荧光校准微球的比率表示的平均细胞荧光与生化测定的0.2 - 2.0 fmol细胞⁻¹范围内的GSH含量之间存在密切相关性。通过23号针头穿刺或手术标本的机械解离制备了来自14种人类癌症的单细胞悬液,用mBCl染色并通过流式细胞术检查。单个细胞荧光存在很大差异,与EMT6细胞不同的是,它与库尔特体积没有强烈相关性。通过将肿瘤细胞荧光与校准微球的荧光进行比较,并假设EMT6细胞与GSH含量的关系对其他细胞也成立,得出9种癌的平均GSH含量为0.95 fmol细胞⁻¹,5种非霍奇金淋巴瘤的平均GSH含量为0.21 fmol细胞⁻¹。尽管这种半定量需要进一步验证,但这里使用的方法快速,能显示肿瘤细胞GSH含量的异质性,并且可应用于细针穿刺活检样本。因此,它有望作为一种前瞻性研究GSH含量与临床药物和放射敏感性关系的手段,以及监测诸如丁硫氨酸亚砜胺等旨在通过消耗肿瘤细胞GSH来改善治疗效果的药物的作用。